$MDLZ

Can Mondelez's Organic Growth Momentum Continue Through 2026?

Mondelez (MDLZ) reported 2.2% organic revenue growth in Q2 2026, driven by volume/mix and pricing. The company raised its full-year outlook to at least 2% growth. Emerging Markets and North America showed strong performance, while Europe lagged due to weather impacts. Shares have risen 15.5% year-to-date, outperforming the industry.

Original reporting
Published Aug 18, 2026, 2:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Can Mondelez's Organic Growth Momentum Continue Through 2026? — source image
Decision brief

The 30-second read

$MDLZBullishMed
01

Why it matters

Traders can use the raised organic growth outlook and the regional drivers (EM/North America strength, Europe weather drag, Latin America inventory timing) to update near-term expectations for MDLZ and potentially peer estimate models.

02

Market read

A guidance raise based on pricing and improving volume/mix is a concrete catalyst, but the article lacks a full earnings release context and does not provide valuation or margin details.

03

What to watch

The article notes a Latin America trade-inventory benefit ahead of SAP S4 implementation, which could partially reverse if inventory dynamics normalize.

Relevance 7/10Novelty 6/10Timing: today’s read-through to 2026 organic growth expectations

Background

The piece frames Mondelez’s 2026 first-half organic growth as being driven by pricing and improving volume/mix, then links that to an outlook increase.

Company-level read

Ticker impact

$MDLZBullishMedium confidence
Context

Mondelez raised its full-year organic net revenue growth outlook to at least 2% after 2Q organic net revenues rose 2.2%.

Expected impact

Likely supportive bias for MDLZ over the next few sessions as traders reprice 2026 organic growth expectations.

Evidence & confidence

The article provides specific 2Q and 1H organic growth components and a clear upward revision versus prior flat-to-2% outlook, which typically drives estimate revisions and multiple expansion, though it is not an earnings print or full financials.

Market effects

Signals resilience in packaged foods demand via pricing and volume/mix, potentially supporting sentiment for other consumer staples with similar pricing power.

Highlights Emerging Markets and North America strength, while Europe remains weather-impacted, which may influence regional demand expectations for peers.

Improving Europe and sustained EM/North America momentum can affect broader risk appetite in global consumer staples growth narratives.

Counterpoint

Europe’s organic revenue decline is attributed to unusually hot weather and volume weakness, so the raised outlook may be more dependent on normalization than on durable demand improvement.

Key entities

  • Mondelez International, Inc.

    Raised full-year organic net revenue growth outlook to at least 2% after 2Q organic net revenues grew 2.2%.

Related articles

$MDLZMedAI 8/10

MDLZ Q2 Sales Beat and Higher 2026 Growth View Put Margins in Focus

Mondelez (MDLZ) reported Q2 net revenue of $9.36B (+4.1% YoY), beating estimates. Adjusted EPS of $0.73 also beat. Organic net revenue grew 2.2%. MDLZ raised its 2026 organic net revenue growth outlook to at least 2%. Operating income declined 6.1% due to higher costs. Management maintained 2026 adjusted EPS growth guidance of flat to 5%.

$MDLZMed

Mondelez International, Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Emerging markets delivered robust 4.4% top-line growth, driven by structural distribution expansion rather than cyclical trends, with India and Brazil reaching significant store milestones. North American performance is characterized by a 'K-shaped' recovery where consumers are simultaneously seeking value formats and premium 'better-for-you' options.

$MDLZMed

Is Wall Street Bullish or Bearish on Mondelez International Stock?

Mondelez International (MDLZ) has lagged the S&P 500 over 52 weeks, down 3.8% versus SPX up 16.5%, though YTD it is up 16.4%. The company cited cocoa cost inflation and North America volume weakness. After Q2 2026 results, it rose over 4% on adjusted EPS of $0.73 and revenue of $9.36B, raising FY organic net revenue growth to at least 2%. Analysts expect 2026 adjusted EPS of $3.04. BTIG raised its price target to $73.

$MDLZMedAI 8/10

Mondelez beats second-quarter estimates on steady demand

Mondelez International reported Q2 adjusted profit of 68 cents, beating the 68-cent consensus, and quarterly net revenue of $9.36B versus a $9.20B estimate, helped by steady demand and higher pricing. It raised its annual organic net revenue growth outlook to at least 2%. North America pricing rose 2.2 points; volumes rose 1.2.